CTXR
Closed
Citius Pharmaceuticals Inc
1.9
+0.3 (+18.87%)
Last Update: 01 Jul 2025 23:24:00
Yesterday: 1.59
Day's Range: 1.6 - 1.9
Send
sign up or login to leave a comment!
When Written:
1.17
Citius Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for various medical needs. The company's primary focus is on developing products for critical care, cancer care, and anti-infectives. Citius Pharmaceuticals Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. The company's lead product candidate is Mino-Lok, a catheter lock solution for the treatment of catheter-related bloodstream infections. Other products in development include Halo-Lido, a topical formulation for the treatment of hemorrhoids, and CitiusIodine, a topical antiseptic solution. Citius Pharmaceuticals Inc. is a publicly traded company listed on the NASDAQ under the ticker symbol CTXR.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








